Adalimumab biosimilar by Biocon for Plaque Psoriasis (Psoriasis Vulgaris): Likelihood of Approval

Adalimumab biosimilar is under clinical development by Biocon and currently in Phase III for Plaque Psoriasis (Psoriasis Vulgaris).

Could Francis Collins’s Prostate Cancer Story Deter Men From Active Surveillance?

Former NIH director Francis Collins, MD, PhD, one of America’s most prominent physicians and the leader of the ground-breaking Human Genome Project, has gone public

April 18, 2024

The 2023 winners and losers list: Who was up and who was down in biopharma

I hate end-of-the-year pieces. They tend to be dull and assigned by some editor who sees the odometer rolling over and thinks that’s more interesting

December 21, 2023

Researchers find differences in how people with impulse control disorder process consequences

Parkinson’s disease is a neurological disorder that affects movement and muscle control. One characteristic of the disease is the deficiency of dopamine, a neurotransmitter or

March 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.